Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT01430286Not ApplicableCompleted

Web-based Psycho-Educational Program to Support Carers of Alzheimer's Patients

Role: collaborator

NCT05686486Not ApplicableCompleted

Gentle Gymnastics and Relationship Between Family Caregivers and Residents With Dementia in Nursing Homes

Role: lead

NCT04573829Not ApplicableCompleted

PsyDoMa : Non-drug Approaches at Home for Alzheimer's Patients With Psycho-behavioural Disorders

Role: collaborator

NCT01095718Not ApplicableUnknown

Comparison of 3 Learning Methods to Improve Independent Activities of Daily Living (IADLs) in Alzheimer Disease

Role: collaborator

All 4 trials loaded